1-ethyl-4-fluoronaphthalene | 55830-92-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 1-ethyl-4-fluoronaphthalene
• 英文别名: 1-Ethyl-4-fluornaphthalin；1-Ethyl-4-fluoronaphthalen
• CAS: 55830-92-7
• 化学式: C₁₂H₁₁F
• 分子量: 174.218
• InChiKey: ZZIGQZHPBZTABT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  4-氟-1-萘乙酮 在 盐酸 、 锌 作用下， 生成 1-ethyl-4-fluoronaphthalene
  参考文献：
  名称：

  Substituent effects. XII. Substituent effects by fluorine-19 NMR

  摘要：

  DOI：

  10.1021/ja00841a034

文献信息

• Substituted 2-(het)arylimidazolylcarboxyamides as pesticides
  申请人：Bayer CropScience Aktiengesellschaft

  公开号：US20190047982A1

  公开（公告）日：2019-02-14

  The present invention relates to compounds of the general formula (I) in which Q, V, T, W, X, Y and A have the meanings given in the description—and to their use for controlling animal pests.

  本发明涉及一般式（I）中的化合物，其中Q、V、T、W、X、Y和A具有描述中给定的含义，以及它们用于控制动物害虫的用途。
• ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
  申请人：BEIJING SUMMER SPROUT TECHNOLOGY CO., LTD.

  公开号：US20220020935A1

  公开（公告）日：2022-01-20

  Disclosed are a novel organic electroluminescent material and a device thereof. Such a novel organic electroluminescent material has a structure of Formula 1, and when applied to the organic electroluminescent device, can improve the balance of electrons and holes in the organic electroluminescent device and thus bring excellent device effects such as the improvement of external quantum efficiency, current efficiency, and service life. The novel organic electroluminescent material can be used to prepare organic semiconductor devices and is suitable for different types of organic semiconductor devices, including but not limited to fluorescent OLEDs, phosphorescent OLEDs, white OLEDs, laminated OLEDs, OTFTs, OPVs, etc. Further disclosed are an electroluminescent device comprising the organic electroluminescent material and a compound formulation comprising the organic electroluminescent material.

  本发明涉及一种新型有机电致发光材料及其器件。所述新型有机电致发光材料具有一种化学结构式1，当应用于有机电致发光器件时，可以改善有机电致发光器件中电子和空穴的平衡，从而带来卓越的器件效果，如提高外部量子效率、电流效率和使用寿命。该新型有机电致发光材料可用于制备有机半导体器件，并适用于不同类型的有机半导体器件，包括但不限于荧光OLED、磷光OLED、白色OLED、层压OLED、OTFT、OPV等。进一步公开了包括所述有机电致发光材料和化合物配方的电致发光器件。
• Arylindenopyridines and related therapeutic and prophylactic methods
  申请人：——

  公开号：US20040082578A1

  公开（公告）日：2004-04-29

  This invention provides novel arylindenopyridines of the formula: 1 and pharmaceutical compositions comprising same, useful for treating disorders ameliorated by antagonizing Adensine A2a receptors or reducing PDE activity in appropriate cells. This invention also provides therapeutic and prophylactic methods using the instant pharmaceutical compositions.

  本发明提供了新型的芳基茚莽啶化合物的公式1及其制成的药物组合物，用于治疗通过拮抗腺苷A2a受体或在适当的细胞中减少PDE活性而改善的疾病。本发明还提供了使用该药物组合物的治疗和预防方法。
• Pharmaceutical compounds
  申请人：Boulet Louis Serge

  公开号：US20070072859A1

  公开（公告）日：2007-03-29

  The present invention relates to inhibitors of serotonin and/or norepinephrine reuptake and specifically provides compounds of formula (I): wherein A is selected from —O— and —S—; X is selected from C 1 -C 8 alkyl, C 2 -C 8 alkenyl, and C 4 -C 8 cycloalkylalkyl, each of which may be optionally substituted with up to 3 substituents each independently selected from phenyl, pyrrolidinyl, piperidinyl, morpholinyl, halo, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl-S(O) n — where n is 0, 1 or 2, —CF 3 , —CN and —CONH 2 ; Y is selected from (a), (b), (c), (d), (e), (f) where R 3 , R 4 and R 5 are independently selected from hydrogen, halo, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl-S(O) n — where n is 0, 1 or 2, nitro, acetyl, —CF 3 , —SCF 3 and cyano; R 6 and R 7 are independently selected from halo, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl-S(O) n — where n is 0, 1 or 2, nitro, acetyl, —CF 3 , —SCF 3 and cyano; R 8 is selected from chloro, bromo, iodo, C 1 -C 4 alkyl, C 1 -C 4 alkoxy, C 1 -C 4 alkyl-S(O) n — where n is 0, 1 or 2, nitro, acetyl, —CF 3 , —SCF 3 and cyano; R 1 and R 2 are each independently hydrogen or C 1 -C 4 alkyl; or pharmaceutically acceptable salts thereof; or compositions thereof and methods of using the same.

  本发明涉及抑制血清素和/或去甲肾上腺素再摄取的抑制剂，具体提供了式（I）的化合物：其中A选自- O-和- S-; X选自C1-C8烷基，C2-C8烯基和C4-C8环烷基烷基，每个基团都可以选择性地被取代，每个基团独立地选自苯基，吡咯烷基，哌啶基，吗啉基，卤素，C1-C4烷基，C1-C4烷氧基，C1-C4烷基-S（O）n-其中n为0、1或2，-CF3，-CN和-CONH2; Y选自（a），（b），（c），（d），（e），（f），其中R3，R4和R5独立地选自氢，卤素，C1-C4烷基，C1-C4烷氧基，C1-C4烷基-S（O）n-其中n为0、1或2，硝基，乙酰，-CF3，-SCF3和氰基; R6和R7独立地选自卤素，C1-C4烷基，C1-C4烷氧基，C1-C4烷基-S（O）n-其中n为0、1或2，硝基，乙酰，-CF3，-SCF3和氰基; R8选自氯，溴，碘，C1-C4烷基，C1-C4烷氧基，C1-C4烷基-S（O）n-其中n为0、1或2，硝基，乙酰，-CF3，-SCF3和氰基; R1和R2各自独立地为氢或C1-C4烷基; 或其药学上可接受的盐; 或其组合物和使用方法。
• PHOSPHOROUS PROTECTING GROUPS AND METHODS OF PREPARATION AND USE THEREOF
  申请人：Agilent Technologies, Inc.

  公开号：US20150315227A1

  公开（公告）日：2015-11-05

  Aspects of the present disclosure include compositions that make use of phosphorus and/or nucleobase protecting groups which find use in the synthesis of long polynucleotides. Phosphorus protecting groups are provided that help increase the stepwise coupling yield and/or phosphorous protecting groups that can be removed during the oxidation step. Amidine nucleobase protecting groups are provided that find use in the subject compositions and methods which provides for e.g., increased resistance to depurination during polynucleotide synthesis. In some instances, the methods and compositions disclosed herein utilize a combination of the phosphorus and amidine nucleobase protecting groups in the synthesis of polynucleotides having a sequence of 200 or more monomeric units in length. Also provided are methods for synthesizing a polynucleotide (e.g., a DNA) using one or more compounds disclosed herein.

  本公开涉及的方面包括使用磷和/或核碱基保护基的组合物，这些组合物用于合成长的多核苷酸。提供了磷保护基，有助于增加逐步耦合产率和/或可以在氧化步骤中去除的磷保护基。提供了酰胺核碱基保护基，用于本主题的组合物和方法，例如在多核苷酸合成过程中提供了增加的去嘌呤作用的抵抗力。在某些情况下，本公开的方法和组合物利用磷和酰胺核碱基保护基的组合合成具有200个或更多单体单位长度序列的多核苷酸。还提供了使用本文所述的一种或多种化合物合成多核苷酸（例如DNA）的方法。